Onward Medical N.V. (ONWRF)

Market Cap	210.71M
Revenue (ttm)	1.76M
Net Income (ttm)	-36.96M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	202
Average Volume	624
Open	4.410
Previous Close	4.750
Day's Range	4.410 - 4.430
52-Week Range	3.770 - 7.130
Beta	0.86
RSI	39.13
Earnings Date	Jun 17, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer inter...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Employees: 99
• Stock Exchange: OTCMKTS
• Ticker Symbol: ONWRF

Financial Performance

In 2024, Onward Medical's revenue was 1.70 million, an increase of 219.55% compared to the previous year's 532,000. Losses were -35.70 million, -1.33% less than in 2023.

Financial numbers in EUR